USD 2904.7 Million in 2020 and is projected to grow at a CAGR of 8.20% between 2017 to 2028 . The study has considered the base year as 2020, which estimates the market size of market and the forecast period is 2021 to 2028

Feature News Market your brand and products to China The Affordable Watches from Megalith Want to be The Mature Men's First Watch La-Z-Boy Asia Management Reveals Secret to Success amid Global Changes 5 Types of Fellow Gamblers That Can Ruin Your Game Aphrodite's New Location in London Are Satta King 2021, Sattaking Gali Satta.com Gaming Systems Good or Bad? What You Should Look After While Searching for SEO Services? UK Wills, Trusts & Lasting Power of Attorney in Cyprus Global Enoxaparin sodium market is estimated to be worth USD 2904.7 Million in 2020 and is projected to grow at a CAGR of 8.20% between 2017 to 2028 . The study has considered the base year as 2020, which estimates the market size of market and the forecast period is 2021 to 2028. The report analyzes and forecasts the market size, in terms of value (USD Million), for the market. The report segments the market and forecasts its size, by drugs type, by application, by sales channels and region/country.

​

Report Sample includes: Table of Contents

List of Tables & Figures

Charts

Research Methodology

​

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/4/enoxaparin-sodium-injection-market

​

​

Enoxaparin sodium is an anticoagulant heparin with a low molecular weight drug (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to treat and prevent blood clots during pregnancy and after certain types of surgery. Pulmonary embolism occurs when blood clots move through the lungs and get stuck in the blood vessels of lungs. This medication is prescribed for a period of time after knee or hip replacement surgery, as well as in some cases of abdominal surgery and also in the event of a major illness. Moreover, enoxaparin sodium is used in those with acute coronary syndrome (ACS) and heart attack. It is injected into a vein or just beneath the skin. Bleeding, fever, and leg swelling are all common adverse effects. Bleeding might be dangerous,

​

Increase in number of Food and Drug Administration approval drugs and surge in the geriatric population are some factors, which boost the market growth. Rise in awareness for the treatment of several cardiovascular disease fuels the market growth. In addition, increase in healthcare expenditure, rise in research & development activities conducted by many pharmaceutical companies, launches of novel developed drug in market are some factors which contribute toward the enoxaparin sodium market growth.

​

The enoxaparin sodium market size is expected to be valued at USD 5334.8 million by 2028. The enoxaparin sodium market is segmented into type, application, and sales channel. Based on the type, enoxaparin sodium market is segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, and others. Based on the application, enoxaparin sodium market is segmented into hospitals, clinics, and others. Based on the sales channel, enoxaparin sodium market is bifurcated into direct channel and indirect channel.

​

This report provides detailed historical analysis of global market for Enoxaparin Sodium Injection from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Enoxaparin Sodium Injection market.

​

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

​

Market Segment Analysis:

​

Leading players of Enoxaparin Sodium Injection including:

​

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

​

The information for each competitor/Company Profile includes:

​

Company Overview

Business Strategy

Key Product Offerings

Financial Performance

Key Performance Indicators

Risk Analysis

Recent Development

Regional Presence

SWOT Analysis

​

Market split by Type, can be divided into:

​

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

​

Market split by Application, can be divided into:

​

Hospital

Clinic

Others

​

Market split by Sales Channel, can be divided into:

​

Direct Channel

Distribution Channel

​

Enoxaparin is commonly used in cardiac patients. As with all low molecular weight heparins, (LMWHs) the drug is easy to administer subcutaneously as compared with intravenous infusion of unfractionated heparin. Unlike other LMWHs, enoxaparin has been shown to be superior to intravenous unfractionated heparin in patients with non-ST elevation and ST elevation acute coronary syndromes (ACS), and a comparable agent in patients undergoing elective percutaneous coronary intervention (PCI) with decreased bleeding. However, elective PCI in patients without ACS is currently not in the enoxaparin label. It primarily inhibits factors Xa and IIa with a greater effect on factor Xa. Enoxaparin is renally cleared and a dose adjustment by 50% reduction is recommended for patients with creatinine clearance below 30 ml/min.

​

Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.

​

The commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global enoxaparin sodium market.

​

Get the Complete Report & TOC at https://www.intelmarketresearch.com/life-sciences/4/enoxaparin-sodium-injection-market

CONTACT US:

276 5th Avenue, New York, NY 10001,United States

International: (+1) 646 781 7170

Email: help@intelmarketresearch.com

​

Follow Us On linkedin :– https://www.linkedin.com/company/intel-market-research